Published in Synapse on April 01, 2010
Eating high fat chow and the behavioral effects of direct-acting and indirect-acting dopamine receptor agonists in female rats. Behav Pharmacol (2014) 0.79
Making Sense of: Sensitization in Schizophrenia. Int J Neuropsychopharmacol (2016) 0.76
Amphetamine locomotor sensitization and conditioned place preference in adolescent male and female rats neonatally treated with quinpirole. Behav Pharmacol (2011) 0.75
The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev (1993) 19.60
Smoking and mental illness: A population-based prevalence study. JAMA (2000) 14.17
A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev (1997) 3.80
Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci U S A (1996) 3.28
Principles and pitfalls in the analysis of prenatal treatment effects in multiparous species. Neurotoxicol Teratol (1992) 2.80
RGS9 modulates dopamine signaling in the basal ganglia. Neuron (2003) 2.61
Specificity in the projection patterns of accumbal core and shell in the rat. Neuroscience (1991) 2.58
Gender differences in dopaminergic function in striatum and nucleus accumbens. Pharmacol Biochem Behav (1999) 2.33
Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Am J Psychiatry (1998) 2.30
Dissociation in conditioned dopamine release in the nucleus accumbens core and shell in response to cocaine cues and during cocaine-seeking behavior in rats. J Neurosci (2000) 2.19
Yawning and hypothermia in rats: effects of dopamine D3 and D2 agonists and antagonists. Psychopharmacology (Berl) (2007) 1.94
To model a psychiatric disorder in animals: schizophrenia as a reality test. Neuropsychopharmacology (2000) 1.89
Psychosis pathways converge via D2high dopamine receptors. Synapse (2006) 1.78
Proposal for a noradrenaline hypothesis of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2004) 1.77
D2 dopamine receptors colocalize regulator of G-protein signaling 9-2 (RGS9-2) via the RGS9 DEP domain, and RGS9 knock-out mice develop dyskinesias associated with dopamine pathways. J Neurosci (2005) 1.74
Striatal amphetamine-induced dopamine release in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123I]iodobenzamide. Biol Psychiatry (2004) 1.71
Does amphetamine preferentially increase the extracellular concentration of dopamine in the mesolimbic system of freely moving rats? Neuropsychopharmacology (1990) 1.65
Segregation of amphetamine reward and locomotor stimulation between nucleus accumbens medial shell and core. J Neurosci (2003) 1.57
The organization of the ascending catecholamine neuron systems in the rat brain as revealed by the glyoxylic acid fluorescence method. Acta Physiol Scand Suppl (1974) 1.56
Gender differences in the behavioral responses to cocaine and amphetamine. Implications for mechanisms mediating gender differences in drug abuse. Ann N Y Acad Sci (2001) 1.38
Amphetamine-induced time-dependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum: a microdialysis study in behaving rats. Synapse (1995) 1.36
Role of noradrenergic signaling by the nucleus tractus solitarius in mediating opiate reward. Science (2006) 1.35
Dopamine release and uptake are greater in female than male rat striatum as measured by fast cyclic voltammetry. Neuroscience (2000) 1.33
Amphetamine produces sensitized increases in locomotion and extracellular dopamine preferentially in the nucleus accumbens shell of rats administered repeated cocaine. J Pharmacol Exp Ther (1995) 1.22
Sex differences in (+)-amphetamine- and (+)-methamphetamine-induced behavioral response in male and female Sprague-Dawley rats. Pharmacol Biochem Behav (2007) 1.18
Schizophrenia: from developmental deviance to dopamine dysregulation. Eur Neuropsychopharmacol (2008) 1.13
Psychostimulant sensitization: differential changes in accumbal shell and core dopamine. Eur J Pharmacol (2000) 1.12
The role of age, genotype, sex, and route of acute and chronic administration of methylphenidate: a review of its locomotor effects. Brain Res Bull (2005) 1.10
Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization. J Pharmacol Exp Ther (1993) 1.06
Catecholamine mapping within nucleus accumbens: differences in basal and amphetamine-stimulated efflux of norepinephrine and dopamine in shell and core. J Neurochem (2007) 1.04
Effects of dopamine agonists and antagonists on locomotor activity in male and female rats. Pharmacol Biochem Behav (2002) 1.03
Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study. J Neurochem (1988) 1.03
A PET study evaluating dopamine D2 receptor occupancy for long-acting injectable risperidone. Am J Psychiatry (2006) 1.01
Consistent with dopamine supersensitivity, RGS9 expression is diminished in the amphetamine-treated animal model of schizophrenia and in postmortem schizophrenia brain. Synapse (2007) 0.95
Dopamine receptor supersensitivity. Neurosci Biobehav Rev (1995) 0.94
Drug addiction. Part II. Neurobiology of addiction. Pol J Pharmacol (2002) 0.94
Turning behaviour as an index of the action of amphetamines and ephedrines on central dopamine-containing neurones. Br J Pharmacol (1971) 0.91
Neurotrophic factors and CNS disorders: findings in rodent models of depression and schizophrenia. Prog Brain Res (2004) 0.91
Association between DRD4 gene and performance of children with ADHD in a test of sustained attention. Biol Psychiatry (2006) 0.91
A differential activation of dopamine output in the shell and core of the nucleus accumbens is associated with the motor responses to addictive drugs: a brain dialysis study in Roman high- and low-avoidance rats. Neuropharmacology (2004) 0.89
Effect of antipsychotic drugs on brain-derived neurotrophic factor expression under reduced N-methyl-D-aspartate receptor activity. J Neurosci Res (2003) 0.88
Schizophrenia and psychostimulant abuse: a review and re-analysis of clinical evidence. Psychopharmacology (Berl) (1995) 0.87
Mapping of locomotor behavioral arousal induced by microinjections of dopamine within nucleus accumbens septi of rat forebrain. Brain Res (1997) 0.85
Polymorphism of DRD2 gene and ADHD. Neuro Endocrinol Lett (2006) 0.85
Drugs of abuse: biochemical surrogates of specific aspects of natural reward? Biochem Soc Symp (1993) 0.84
Differential effects of delta- and mu-opioid receptor antagonists on the amphetamine-induced increase in extracellular dopamine in striatum and nucleus accumbens. J Neurochem (1996) 0.83
In vivo regulation of dopamine and noradrenaline release by alpha2A-adrenoceptors in the mouse nucleus accumbens. J Neurochem (2004) 0.83
Low-dose quinpirole ontogenically sensitizes to quinpirole-induced yawning in rats. Pharmacol Biochem Behav (1993) 0.83
Norepinephrine in chronic paranoid schizophrenia: above-normal levels in limbic forebrain. Science (1978) 0.82
Locomotor sensitization to quinpirole in rats: effects of drug abstinence and sex. Psychopharmacology (Berl) (2000) 0.82
Amphetamine-induced enhancement of neostriatal in vivo microdialysate dopamine content in rats, quinpirole-primed as neonates. Pol J Pharmacol (2002) 0.81
Acute amphetamine-induced subsensitivity of A10 dopamine autoreceptors in vitro. Brain Res (1991) 0.81
Alpha2-adrenergic control of dopamine overflow and metabolism in mouse striatum. Eur J Pharmacol (1997) 0.80
Serious mental illness and smoking cessation. Issues Ment Health Nurs (2006) 0.80
Alpha 2 and beta-adrenoceptor agonists modulate [3H]dopamine release from rat nucleus accumbens slices: implications for research into depression. Neurochem Res (1984) 0.80
Opposing role of dopamine D1 and D2 receptors in modulation of rat nucleus accumbens noradrenaline release. J Neurosci (1999) 0.80
Neonatal ventral hippocampal lesions potentiate amphetamine-induced increments in dopamine efflux in the core, but not the shell, of the nucleus accumbens. Biol Psychiatry (2006) 0.80
Long-term opiate effects on amphetamine-induced dopamine release in the nucleus accumbens core and conditioned place preference. Pharmacol Biochem Behav (2004) 0.79
Nicotine sensitization in adult male and female rats quinpirole-primed as neonates. Psychopharmacology (Berl) (2008) 0.79
Phencyclidine and (+)-MK-801-induced circling preference: correlation with monoamine levels in striatum of the rat brain. Neurotoxicol Teratol (1994) 0.78
Role of the nucleus accumbens and the striatum in the production of turning behaviour in intact rats. Rev Neurosci (1995) 0.78
Analysis of behavioral asymmetries in the elevated plus-maze and in the T-maze. J Neurosci Methods (2005) 0.78
The effects of adulthood olanzapine treatment on cognitive performance and neurotrophic factor content in male and female rats neonatally treated with quinpirole. Eur J Neurosci (2006) 0.77
Ontogenetic quinpirole treatment produces long-lasting decreases in the expression of Rgs9, but increases Rgs17 in the striatum, nucleus accumbens and frontal cortex. Eur J Neurosci (2007) 0.77
Nicotine-induced sensitization in mice: changes in locomotor activity and mesencephalic gene expression. Neurochem Res (2005) 0.77
Yawning induced by the selective dopamine D2 agonist N-0437 is blocked by the selective dopamine autoreceptor antagonist (+)-UH 232. Physiol Behav (1989) 0.76
Postmortem central catecholamines and antemortem cognitive impairment in elderly schizophrenics and controls. Neuropsychobiology (1985) 0.76
Ontogenetic quinpirole treatment induces vertical jumping activity in rats. Eur J Pharmacol (1993) 0.76
Plagiarism among applicants for faculty positions. Am J Pharm Educ (2011) 0.97
Conserved dorsal-ventral gradient of dopamine release and uptake rate in mice, rats and rhesus macaques. Neurochem Int (2012) 0.93
A chronic iron-deficient/high-manganese diet in rodents results in increased brain oxidative stress and behavioral deficits in the morris water maze. Neurotox Res (2009) 0.93
Neonatal methamphetamine administration induces region-specific long-term neuronal morphological changes in the rat hippocampus, nucleus accumbens and parietal cortex. Eur J Neurosci (2004) 0.93
Hydroxyl-substituted sulfonylureas as potent inhibitors of specific [3H]glyburide binding to rat brain synaptosomes. Bioorg Med Chem (2003) 0.91
The effect of nicotine on sign-tracking and goal-tracking in a Pavlovian conditioned approach paradigm in rats. Psychopharmacology (Berl) (2012) 0.89
Expression levels of genes likely involved in glucose-sensing in the obese Zucker rat brain. Nutr Neurosci (2004) 0.88
Gestational IV nicotine produces elevated brain-derived neurotrophic factor in the mesocorticolimbic dopamine system of adolescent rat offspring. Synapse (2011) 0.88
Distribution of glucokinase, glucose transporter GLUT2, sulfonylurea receptor-1, glucagon-like peptide-1 receptor and neuropeptide Y messenger RNAs in rat brain by quantitative real time RT-PCR. Brain Res Mol Brain Res (2003) 0.85
Dopamine receptor supersensitivity: development, mechanisms, presentation, and clinical applicability. Neurotox Res (2008) 0.84
Short-term food restriction and refeeding alter expression of genes likely involved in brain glucosensing. Exp Biol Med (Maywood) (2003) 0.83
Evidence for hypothalamic K+(ATP) channels in the modulation of glucose homeostasis. Eur J Pharmacol (2004) 0.81
Nicotine sensitization in adult male and female rats quinpirole-primed as neonates. Psychopharmacology (Berl) (2008) 0.79
Nicotine sensitization and analysis of brain-derived neurotrophic factor in adolescent beta-arrestin-2 knockout mice. Synapse (2009) 0.79
Sex differences in nicotine sensitization and conditioned hyperactivity in adolescent rats neonatally treated with quinpirole: role of D2 and D3 receptor subtypes. Behav Neurosci (2009) 0.79
Methylphenidate place conditioning in adolescent rats: an analysis of sex differences and the dopamine transporter. Behav Brain Res (2013) 0.78
Sex and dose-related differences in methylphenidate adolescent locomotor sensitization and effects on brain-derived neurotrophic factor. J Psychopharmacol (2012) 0.78
The role of dopamine D₁ and D₂ receptors in adolescent methylphenidate conditioned place preference: sex differences and brain-derived neurotrophic factor. Dev Neurosci (2014) 0.78
Adolescent nicotine sensitization and effects of nicotine on accumbal dopamine release in a rodent model of increased dopamine D2 receptor sensitivity. Behav Brain Res (2013) 0.77
Ontogenetic quinpirole treatment produces long-lasting decreases in the expression of Rgs9, but increases Rgs17 in the striatum, nucleus accumbens and frontal cortex. Eur J Neurosci (2007) 0.77
The effects of adulthood olanzapine treatment on cognitive performance and neurotrophic factor content in male and female rats neonatally treated with quinpirole. Eur J Neurosci (2006) 0.77
An analysis of nicotine conditioned place conditioning in early postweanling and adolescent rats neonatally treated with quinpirole. Behav Brain Res (2011) 0.77
Eszopiclone facilitation of the antidepressant efficacy of fluoxetine using a social defeat stress model. Pharmacol Biochem Behav (2011) 0.77
Schizophrenia and substance abuse comorbidity: nicotine addiction and the neonatal quinpirole model. Dev Neurosci (2012) 0.77
Intravenous Prenatal Nicotine Exposure Alters METH-Induced Hyperactivity, Conditioned Hyperactivity, and BDNF in Adult Rat Offspring. Dev Neurosci (2016) 0.75
Amphetamine locomotor sensitization and conditioned place preference in adolescent male and female rats neonatally treated with quinpirole. Behav Pharmacol (2011) 0.75
Corticosterone administration up-regulated expression of norepinephrine transporter and dopamine β-hydroxylase in rat locus coeruleus and its terminal regions. J Neurochem (2013) 0.75
Effects of sarizotan in animal models of ADHD: challenging pharmacokinetic-pharmacodynamic relationships. J Neural Transm (Vienna) (2015) 0.75
Preface. Dev Neurosci (2012) 0.75